Wednesday, April 05, 2017 9:38:42 AM
I have very little experience in the medical field nor have I ever played a part in medical, clinical trials. Being in the "chemical" industry now for a better part of a decade, I certainly understand the processes and have become accustomed to them through earshot and colleagues in the industry.
I can assure you, based on the evidence presented and the DD I've been personally doing reaching back as far as I can, there is a study going on. That is certain. To say there isn't even a study is just outlandish and it's just plain false. If you're going to make such claims and label that as facts, please present your evidence.
You make a valid point about them not releasing technical data associated with the study. This is true, they obviously haven't. It's for reasons that come with protecting IP and how easily it can be swiped from them that they probably do this.
I'm personally invested in OWCP and have been for a while now. I've been reading for months without posting.
Enough is enough. The slander and squeezing have gone on long enough. You won't win this.
OWCP longs know what they own. They remain diligent and strong. Try as you might, we will be sure to wave when the ship sails and you're left at the dock.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM